The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 13, 2010
Filed:
Oct. 19, 2006
Rosana Kapeller-libermann, Chestnut Hill, MA (US);
John Joseph Hunter, Somerville, MA (US);
Rachel E. Meyers, Newton, MA (US);
Laura A. Rudolph-owen, Medford, MA (US);
Rory A. J. Curtis, Framingham, MA (US);
Peter J. Olandt, Newton, MA (US);
Fong-ying Tsai, Newton, MA (US);
Katherine M. Galvin, Jamaica Plain, MA (US);
Miyoung Chun, Belmont, MA (US);
Mark J. Williamson, Saugus, MA (US);
Inmaculada Silos-santiago, Del Mar, CA (US);
Rajasekhar Bandaru, Watertown, MA (US);
Rosana Kapeller-Libermann, Chestnut Hill, MA (US);
John Joseph Hunter, Somerville, MA (US);
Rachel E. Meyers, Newton, MA (US);
Laura A. Rudolph-Owen, Medford, MA (US);
Rory A. J. Curtis, Framingham, MA (US);
Peter J. Olandt, Newton, MA (US);
Fong-Ying Tsai, Newton, MA (US);
Katherine M. Galvin, Jamaica Plain, MA (US);
Miyoung Chun, Belmont, MA (US);
Mark J. Williamson, Saugus, MA (US);
Inmaculada Silos-Santiago, Del Mar, CA (US);
Rajasekhar Bandaru, Watertown, MA (US);
Millennium Pharmaceuticals, Inc., Cambridge, MA (US);
Abstract
The invention provides isolated nucleic acids molecules, designated 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, h1983, m1983, 38555 and 593 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, h1983, m1983, 38555 and 593 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, h1983, m1983, 38555 or 593 gene has been introduced or disrupted. The invention still further provides isolated 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, h1983, m1983, 38555 or 593 proteins, fusion proteins, antigenic peptides and anti-21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, h1983, m1983, 38555 or 593 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.